Last update :
28/04/2024
References   References 3498  
Type : Journal
Web link : https://doi.org/10.1345/aph.1L273

Research teams : Napa - Dey L.P, Analytical Development
Authors : Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
Title : Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Reference : Ann Pharmacotherapy ; 42, 10: 1416-1424. 2008

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
AerosolBudesonide Anti-inflammatory
AerosolCromoglycate sodium Various
AerosolFormoterol fumarate Beta-stimulant
AerosolIpratropium bromide Antimuscarinic
AerosolN-acetylcysteine Various
Stability of mixtures
Glass 25°C Not specified
Aerosol Budesonide Commercial Drug product  0,5 mg/2mL
Aerosol Formoterol fumarate Commercial Drug product  20 µg/2mL
1 Hour
Glass 25°C Not specified
Aerosol Cromoglycate sodium Commercial Drug product  20 mg/mL
Aerosol Formoterol fumarate Commercial Drug product  20 µg/2mL
1 Hour
Glass 25°C Not specified
Aerosol Ipratropium bromide Commercial Drug product  0,5 mg/2,5mL
Aerosol Formoterol fumarate Commercial Drug product  20 µg/2mL
1 Hour
Glass 25°C Not specified
Aerosol N-acetylcysteine Commercial Drug product  100 mg/mL
Aerosol Formoterol fumarate Commercial Drug product  20 µg/2mL
1 Hour

  Mentions Légales